Unit
- Hereditary cancer syndromes: Genetic mutations passed through families that significantly increase cancer risk. Examples include BRCA1/BRCA2 mutations for breast and ovarian cancer, and Lynch syndrome for colorectal cancer. Understanding these syndromes is foundational for program operations.
- Inheritance patterns: Most hereditary cancer syndromes follow an autosomal dominant pattern, meaning a single copy of the mutated gene can increase risk. This affects how family history is assessed and which relatives are offered testing.
- Penetrance and expressivity: Not all mutation carriers develop cancer (incomplete penetrance), and those who do may have varying ages of onset and cancer types. Operations must account for risk stratification beyond mutation status.
- Common syndromes in practice: Hereditary breast and ovarian cancer (HBOC), Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome are frequently encountered in clinical programs. Each has distinct management guidelines.
- Role of genetic counseling: Genetic counselors interpret family histories, explain risks, and facilitate informed decision-making. Program operations depend on integrating counseling services into patient workflows.
- Genetic testing technologies: Next-generation sequencing panels allow simultaneous analysis of multiple genes. Operations must manage test selection, sample handling, and result disclosure logistics.
- Impact on family members: A positive result has implications for blood relatives. Programs often provide cascade testing services to identify at-risk family members and coordinate their evaluation.
- Risk management options: Mutation carriers may choose enhanced screening, chemoprevention, or risk-reducing surgeries. Operations support these pathways through scheduling, referrals, and follow-up.
- Tumor testing and reflex testing: Many programs begin with tumor testing for mismatch repair or homologous recombination deficiency. Positive findings trigger genetic counseling and germline testing. Operations must coordinate specimen handling and reporting to ensure timely follow-up and avoid redundant testing.
- Variant classification and reclassification: Laboratories classify variants as pathogenic, benign, or variants of uncertain significance (VUS). Operations need protocols for periodic reclassification updates, notifying patients and providers when a VUS is reclassified, and adjusting risk management accordingly.
- Insurance and preauthorization processes: Genetic testing often requires prior authorization and medical necessity documentation. Operational teams handle benefit verification, genetic counseling notes, and appeals to reduce patient out-of-pocket costs and testing delays.
- Multidisciplinary coordination: Hereditary cancer programs involve geneticists, surgeons, oncologists, radiologists, and dietitians. Operations facilitate case conferences, shared care plans, and clear communication channels to align management recommendations across specialties.
Terminology
- Hereditary cancer syndrome
- A condition caused by an inherited genetic mutation that increases lifetime cancer risk, often with early onset and multiple primary cancers.
- Penetrance
- The proportion of individuals with a specific genetic mutation who develop the associated condition.
- Cascade testing
- The systematic process of offering genetic testing to at-risk relatives of an individual with a known mutation.
Quick Revision
- Hereditary cancer syndromes stem from inherited mutations and follow autosomal dominant inheritance patterns.
- Common syndromes include HBOC, Lynch syndrome, and familial adenomatous polyposis.
- Genetic counseling and testing logistics are central to operational planning.
- Cascade testing extends care to at-risk family members.